De Serres, G., Skowronski, D. M., Wu, X. W., & Ambrose, C. S. (2013). The test-negative design: Validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro surveillance : bulletin européen sur les maladies transmissibles, 18(37), 1. https://doi.org/10.2807/1560-7917.ES2013.18.37.20585
Chicago Style (17th ed.) CitationDe Serres, G., D M. Skowronski, X W. Wu, and C S. Ambrose. "The Test-negative Design: Validity, Accuracy and Precision of Vaccine Efficacy Estimates Compared to the Gold Standard of Randomised Placebo-controlled Clinical Trials." Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles 18, no. 37 (2013): 1. https://doi.org/10.2807/1560-7917.ES2013.18.37.20585.
MLA (9th ed.) CitationDe Serres, G., et al. "The Test-negative Design: Validity, Accuracy and Precision of Vaccine Efficacy Estimates Compared to the Gold Standard of Randomised Placebo-controlled Clinical Trials." Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles, vol. 18, no. 37, 2013, p. 1, https://doi.org/10.2807/1560-7917.ES2013.18.37.20585.